Guangdong Hybribio Biotech Co Ltd Class A 300639
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 300639 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CNY 6.20
- Day Range
- CNY 5.98–6.33
- 52-Week Range
- CNY 5.65–11.19
- Bid/Ask
- CNY 6.27 / CNY 6.28
- Market Cap
- CNY 4.06 Bil
- Volume/Avg
- 11.4 Mil / 7.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 30.69
- Price/Sales
- 3.15
- Dividend Yield (Trailing)
- 5.65%
- Dividend Yield (Forward)
- 5.65%
- Total Yield
- 5.65%
Company Profile
Guangdong Hybribio Biotech Co Ltd is a Chinese company engaged in offering vitro diagnostic assays. Its products include in-vitro diagnostic kits, female sample collection kit, DNA extraction kit, and other devices. The company's products help in the infectious pathogens detection and genetic disease detection, including human papillomavirus, thalassemia, G6PD, hearing loss susceptibility, phenylketonuria, and early cancer detection, among others. The company has a business presence in China and various other countries.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 2,669
- Website
- http://www.hybribio.cn
Comparables
Valuation
|
Metric
|
300639
|
300289
|
300463
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.69 | — | 24.45 |
Price/Book Value | 0.83 | 1.42 | 1.22 |
Price/Sales | 3.15 | 5.17 | 2.78 |
Price/Cash Flow | 13.60 | 20.70 | 10.66 |
Price/Earnings
300639
300289
300463
Financial Strength
|
Metric
|
300639
|
300289
|
300463
|
|---|---|---|---|
Quick Ratio | 5.86 | 9.47 | — |
Current Ratio | 6.25 | 10.39 | — |
Interest Coverage | 1.67 | 17.73 | — |
Quick Ratio
300639
300289
300463
Profitability
|
Metric
|
300639
|
300289
|
300463
|
|---|---|---|---|
Return on Assets (Normalized) | — | −0.13% | 4.64% |
Return on Equity (Normalized) | — | −0.14% | 6.05% |
Return on Invested Capital (Normalized) | — | −0.79% | 5.41% |
Return on Assets
300639
300289
300463
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Bghlpnrp | Rxwm | $209.3 Bil | |
DHR
| Danaher Corp | Qsjtgkvdb | Trktpn | $182.1 Bil | |
IQV
| IQVIA Holdings Inc | Jsqpgknm | Wmktnt | $42.8 Bil | |
IDXX
| IDEXX Laboratories Inc | Tgyzdprlr | Dsvskg | $41.5 Bil | |
A
| Agilent Technologies Inc | Nxxgzrvkt | Ybby | $40.4 Bil | |
MTD
| Mettler-Toledo International Inc | Jrrjyvprtf | Yczxhv | $26.5 Bil | |
ICLR
| Icon PLC | Ccjphqzy | Msrwfp | $24.8 Bil | |
ILMN
| Illumina Inc | Nxjgyjtqq | Ndylpd | $19.5 Bil | |
WAT
| Waters Corp | Fksyvmqrx | Frcsy | $18.5 Bil | |
LH
| Laboratory Corp of America Holdings | Zlgstzzcyx | Hmltdc | $16.7 Bil |